Q32 Bio Inc. Equity Method Investment, Aggregate Cost
Q32 Bio Inc. (FIXX) had Equity Method Investment, Aggregate Cost of $0 as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes
us-gaap:EquityMethodInvestmentAggregateCost · last filed 2026-03-10
- 2025-12-31: Equity Method Investment, Aggregate Cost $0.00.
- 2025-09-30: Equity Method Investment, Aggregate Cost $0.00.
- 2025-06-30: Equity Method Investment, Aggregate Cost $0.00.
- 2025-03-31: Equity Method Investment, Aggregate Cost $2.53M.
| Period end | Equity Method Investment, Aggregate Cost |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-10 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 |
| 2025-03-31 | $2.53M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.60M 10-K · filed 2026-03-10 |
| 2024-09-30 | $2.60M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $3.27M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $4.72M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-11 |
| 2022-12-31 | $25.81M 10-K · filed 2024-03-13 |
| 2022-09-30 | $27.13M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $29.30M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $30.64M 10-Q · filed 2022-05-16 |
| 2022-03-10 | $74.10M 10-K · filed 2026-03-10 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-09 |